Nielsen Hobbs

Nielsen has been covering pharma most of his life, reporting on everything from ANDAs to Zika vaccines. He believes that the user fee system needs to stop using Roman numerals and enjoys discussing R2-D2 almost as much as talking about 351(k).

Page 1 of 1

Watchdog Wednesday: How To Avoid Starring In A Harrison Ford Movie

Aug 12, 2026 Nielsen Hobbs 8 min read members

Business Men Using Digital Tablets Receiving Bad and God News While Sitting on Park Bench

Watchdog Wednesday: Good (Or Maybe Bad) News On Medicare Price Controls

New Part D figures show the negotiation squeeze has been less tight than pharma may have feared, but program costs are spiking, meaning industry will continue to be in the crosshairs.

Aug 5, 2026 Nielsen Hobbs 4 min read members

Woman Wearing Cowboy Hat On Horse Looking Off At Golden Hour of Sunset With Cloudy Sky

Watchdog Wednesday: Europe’s Top Drug Regulator Rides Off, Slowly

As the US FDA cycled through lots of leadership drama, Europe simply extended Emer Cooke’s mandate as head of EMA. Stability bought the EU a great deal, but hasn’t offered answers on vaccine trust, shortages, pricing, or AI.

Jul 29, 2026 Nielsen Hobbs 6 min read members

Watchdog Wednesday: Is FDA’s Manufacturing Guidance A Trojan Horse?

US FDA says it is offering firms formatting and structure advice on how best to respond to a Form 483 to speed the clearance process. Industry worries the agency is in fact creating new GMP obligations.

Jul 22, 2026 Nielsen Hobbs 5 min read members

Watchdog Wednesday: The Last CRL Before the Lights Went Out

US FDA has resumed posting its complete response letters, but the CRL for AbbVie’s Botox follow-on, the last one issued before the agency’s pause, is still worth lingering over because of what it says about drug development and government reimbursement.

Jul 15, 2026 Nielsen Hobbs 4 min read members

A raised red-and-white barrier gate beside an ascending white staircase on a blue background.

Watchdog Wednesday: Turning The Clinical Trial Inspection Into A Sales Pitch

Health Canada is offering sponsors a no-fault inspection before the new ICH GCP guideline goes into effect, and the bid reveals how regulatory oversight is becoming something of a recruiting tool.

Jul 8, 2026 Nielsen Hobbs 6 min read members

A spectator in silhouette leans over a glass railing and raises an arm toward a baseball field during a night game, with two players standing on the infield below.

Watchdog Wednesday: When Enforcing Your Patent Becomes A Problem

The FTC has told a federal appeals court that what J&J did to competition matters more than what it meant to do. That, along with a big recent Takeda verdict, should change how you think about every defensive patent move.

Jul 1, 2026 Nielsen Hobbs 5 min read members Featured

Watchdog Wednesday: The First JCA Was a Fire Drill

The EU’s debut Joint Clinical Assessment was run on a drug that exposes every trap waiting for orphan developers in 2028.

Jun 24, 2026 Nielsen Hobbs 6 min read members

In the foreground is a chess board with a queen patterned to resemble the UK flag. In the background there is a blurry hospital bed with an in-focus IV line.

Watchdog Wednesday: The UK’s Express Lane for Latecomers

The UK's new "notifiable trial" route can shave weeks off your timeline, but only if you sequence your jurisdictions like a chess player rather than a tourist.

Jun 10, 2026 Nielsen Hobbs 5 min read members

Watchdog Wednesday: US FDA’s AI Trial Revolution Gets Rescheduled

The AI trial pilot survived its own architects' departure. For one more month, the docket is where it gets decided.

Jun 3, 2026 Nielsen Hobbs 4 min read members

Watchdog Wednesday: The EU’s Modular Exclusivity Era Has Arrived

The EU pharma reform package has a 2028 implementation date. That is not a reason to wait.

May 27, 2026 Nielsen Hobbs 5 min read members

Watchdog Wednesday: The FDA's New Front Door Is Not Where You Think

Meetings often get a bad rap around the office water cooler or in popular media, be it through Jack Donaghy’s “Four Chairs. Four!” line in 30 Rock or the

May 20, 2026 Nielsen Hobbs 5 min read members